A breast cancer diagnosis can be terrifying, but one type of early-stage disease is noninvasive and has high survival odds.

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced positive topline results from the pivotal ...

Facing a breast cancer diagnosis can be an overwhelming experience, filled with uncertainty and fear, but knowledge is a ...

Adenocarcinoma in situ (AIS) of the lung —previously included in the category of "bronchioloalveolar carcinoma" (BAC)—is a subtype of lung adenocarcinoma. It tends to arise in the distal bronchioles ...

A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer ... Of the four major pathological responders, one patient had residual SCC in situ, one patient had a pCR at the primary ...

NC, nuclear protein in testis carcinoma; OS, overall survival. Furthermore, the prevalence of NC was assessed in comparison with that of LUSC and HNSC. Of the 17,156 squamous cell cancers (SCCs) of ...

Most lung cancers are called non-small cell lung cancer (NSCLC). This group includes: adenocarcinoma squamous cell carcinoma large cell carcinoma ALK-positive lung cancer The second, smaller ...

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

KEYTRUDA, in combination with pemetrexed and platinum chemotherapy, is indicated for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC ... cancer ...